When to Seek Care: Red Flags For most people, side effects are mild to moderate and feel manageable
Early evidence suggests GLP-1s may reduce chronic inflammation and improve cellular function, supporting heart, liver, kidney, and brain health, and potentially lowering risk for obesity-related cancers
Adherence and Persistence Medication non-adherence is higher in obesity patients compared to diabetes patients
Purpose-built for physicians GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Combination therapy with a GLP-1 receptor agonist and an SGLT2 inhibitor may provide better weight-loss benefits than a single agent for women with polycystic ovary syndrome and obesity, according to study data
Early research in both animals and humans suggests that these treatments may help reduce alcohol and other substance use, commented the reviews lead researcher, Lorenzo Leggio, M.D., Ph.D
A miscalculation here is not a minor error